Listed

Vaxcyte, Inc.

PCVXNasdaqCIK 1649094HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$302.8m, Q2 FY2026
Net income−$284.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m97.4Research and development, Q3 FY2023, three months to 2023-09-30$97.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figure104Research and development, Q4 FY2023, three months to 2023-12-31$104.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure94.6Research and development, Q1 FY2024, three months to 2024-03-31$94.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure132Research and development, Q2 FY2024, three months to 2024-06-30$131.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure117Research and development, Q3 FY2024, three months to 2024-09-30$116.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure134Research and development, Q4 FY2024, three months to 2024-12-31$133.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure148Research and development, Q1 FY2025, three months to 2025-03-31$148.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure194Research and development, Q2 FY2025, three months to 2025-06-30$194.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure210Research and development, Q3 FY2025, three months to 2025-09-30$209.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure242Research and development, Q4 FY2025, three months to 2025-12-31$242.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure313Research and development, Q1 FY2026, three months to 2026-03-31$312.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure268Research and development, Q2 FY2026, three months to 2026-06-30$267.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Operating income$m(113)Operating income, Q3 FY2023, three months to 2023-09-30−$113.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figure(197)Operating income, Q4 FY2023, three months to 2023-12-31−$196.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(114)Operating income, Q1 FY2024, three months to 2024-03-31−$114.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure(153)Operating income, Q2 FY2024, three months to 2024-06-30−$153.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure(140)Operating income, Q3 FY2024, three months to 2024-09-30−$139.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure(162)Operating income, Q4 FY2024, three months to 2024-12-31−$162.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(181)Operating income, Q1 FY2025, three months to 2025-03-31−$180.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure(226)Operating income, Q2 FY2025, three months to 2025-06-30−$226.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure(242)Operating income, Q3 FY2025, three months to 2025-09-30−$242.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure(274)Operating income, Q4 FY2025, three months to 2025-12-31−$274.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(346)Operating income, Q1 FY2026, three months to 2026-03-31−$345.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure(303)Operating income, Q2 FY2026, three months to 2026-06-30−$302.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-06, accession 0000950170-23-059395.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-27, accession 0000950170-24-021145. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-06, accession 0000950170-23-059395.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Net income$m(92.7)Net income, Q3 FY2023, three months to 2023-09-30−$92.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figure(181)Net income, Q4 FY2023, three months to 2023-12-31−$180.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(95.0)Net income, Q1 FY2024, three months to 2024-03-31−$95.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure(129)Net income, Q2 FY2024, three months to 2024-06-30−$128.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure(103)Net income, Q3 FY2024, three months to 2024-09-30−$103.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure(137)Net income, Q4 FY2024, three months to 2024-12-31−$137.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(141)Net income, Q1 FY2025, three months to 2025-03-31−$140.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure(167)Net income, Q2 FY2025, three months to 2025-06-30−$166.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure(213)Net income, Q3 FY2025, three months to 2025-09-30−$212.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure(247)Net income, Q4 FY2025, three months to 2025-12-31−$246.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(321)Net income, Q1 FY2026, three months to 2026-03-31−$320.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure(284)Net income, Q2 FY2026, three months to 2026-06-30−$284.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Diluted EPS$ per share(0.91)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figurenot reported(0.85)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure(1.10)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure(0.83)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figurenot reported(1.04)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure(1.22)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure(1.56)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figurenot reported(2.30)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$2.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure(1.97)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Basic EPS$ per share(0.91)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figurenot reported(0.85)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure(1.10)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure(0.83)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figurenot reported(1.04)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure(1.22)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure(1.56)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figurenot reported(2.30)Basic EPS, Q1 FY2026, three months to 2026-03-31−$2.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure(1.97)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure

Balance sheet

Cash and equivalents$183.2m, Q2 FY2026
Shareholders' equity$2.76bn, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m545Cash and equivalents, Q3 FY2023, at 2023-09-30$545.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0000950170-23-059395.Report this figure397Cash and equivalents, FY2023, at 2023-12-31$397.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001649094-26-000007.Report this figure612Cash and equivalents, Q1 FY2024, at 2024-03-31$611.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure519Cash and equivalents, Q2 FY2024, at 2024-06-30$518.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure1,050Cash and equivalents, Q3 FY2024, at 2024-09-30$1.05bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure388Cash and equivalents, FY2024, at 2024-12-31$387.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001649094-26-000007.Report this figure347Cash and equivalents, Q1 FY2025, at 2025-03-31$346.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure307Cash and equivalents, Q2 FY2025, at 2025-06-30$306.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure281Cash and equivalents, Q3 FY2025, at 2025-09-30$281.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure174Cash and equivalents, FY2025, at 2025-12-31$174.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure261Cash and equivalents, Q1 FY2026, at 2026-03-31$260.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure183Cash and equivalents, Q2 FY2026, at 2026-06-30$183.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Current assets$m1,295Current assets, Q3 FY2023, at 2023-09-30$1.30bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0000950170-23-059395.Report this figure1,096Current assets, FY2023, at 2023-12-31$1.10bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0001649094-25-000028.Report this figure1,517Current assets, Q1 FY2024, at 2024-03-31$1.52bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001628280-24-021677.Report this figure1,481Current assets, Q2 FY2024, at 2024-06-30$1.48bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001649094-24-000052.Report this figure2,214Current assets, Q3 FY2024, at 2024-09-30$2.21bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figure1,788Current assets, FY2024, at 2024-12-31$1.79bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-24, accession 0001649094-26-000007.Report this figure1,717Current assets, Q1 FY2025, at 2025-03-31$1.72bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure1,716Current assets, Q2 FY2025, at 2025-06-30$1.72bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure1,767Current assets, Q3 FY2025, at 2025-09-30$1.77bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure1,627Current assets, FY2025, at 2025-12-31$1.63bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure1,813Current assets, Q1 FY2026, at 2026-03-31$1.81bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure1,553Current assets, Q2 FY2026, at 2026-06-30$1.55bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Total assets$m1,496Total assets, Q3 FY2023, at 2023-09-30$1.50bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0000950170-23-059395.Report this figure1,408Total assets, FY2023, at 2023-12-31$1.41bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0001649094-25-000028.Report this figure2,091Total assets, Q1 FY2024, at 2024-03-31$2.09bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001628280-24-021677.Report this figure2,087Total assets, Q2 FY2024, at 2024-06-30$2.09bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001649094-24-000052.Report this figure3,560Total assets, Q3 FY2024, at 2024-09-30$3.56bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figure3,511Total assets, FY2024, at 2024-12-31$3.51bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001649094-26-000007.Report this figure3,378Total assets, Q1 FY2025, at 2025-03-31$3.38bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure3,305Total assets, Q2 FY2025, at 2025-06-30$3.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure3,172Total assets, Q3 FY2025, at 2025-09-30$3.17bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure3,003Total assets, FY2025, at 2025-12-31$3.00bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure3,348Total assets, Q1 FY2026, at 2026-03-31$3.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure3,138Total assets, Q2 FY2026, at 2026-06-30$3.14bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Current liabilities$m85.6Current liabilities, Q3 FY2023, at 2023-09-30$85.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0000950170-23-059395.Report this figure145Current liabilities, FY2023, at 2023-12-31$145.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0001649094-25-000028.Report this figure87.1Current liabilities, Q1 FY2024, at 2024-03-31$87.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001628280-24-021677.Report this figure82.8Current liabilities, Q2 FY2024, at 2024-06-30$82.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001649094-24-000052.Report this figure124Current liabilities, Q3 FY2024, at 2024-09-30$123.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figure140Current liabilities, FY2024, at 2024-12-31$140.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-24, accession 0001649094-26-000007.Report this figure97.0Current liabilities, Q1 FY2025, at 2025-03-31$97.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure154Current liabilities, Q2 FY2025, at 2025-06-30$154.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure200Current liabilities, Q3 FY2025, at 2025-09-30$200.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure206Current liabilities, FY2025, at 2025-12-31$205.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure242Current liabilities, Q1 FY2026, at 2026-03-31$242.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure271Current liabilities, Q2 FY2026, at 2026-06-30$271.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Total liabilities$m93.3Total liabilities, Q3 FY2023, at 2023-09-30$93.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0000950170-23-059395.Report this figure167Total liabilities, FY2023, at 2023-12-31$167.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0001649094-25-000028.Report this figure107Total liabilities, Q1 FY2024, at 2024-03-31$107.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001628280-24-021677.Report this figure101Total liabilities, Q2 FY2024, at 2024-06-30$101.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001649094-24-000052.Report this figure142Total liabilities, Q3 FY2024, at 2024-09-30$142.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figure205Total liabilities, FY2024, at 2024-12-31$205.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001649094-26-000007.Report this figure178Total liabilities, Q1 FY2025, at 2025-03-31$178.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure234Total liabilities, Q2 FY2025, at 2025-06-30$234.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure279Total liabilities, Q3 FY2025, at 2025-09-30$278.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure317Total liabilities, FY2025, at 2025-12-31$317.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure352Total liabilities, Q1 FY2026, at 2026-03-31$352.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure380Total liabilities, Q2 FY2026, at 2026-06-30$380.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure
Shareholders' equity$m1,403Shareholders' equity, Q3 FY2023, at 2023-09-30$1.40bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figure1,240Shareholders' equity, FY2023, at 2023-12-31$1.24bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001649094-26-000007.Report this figure1,984Shareholders' equity, Q1 FY2024, at 2024-03-31$1.98bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure1,986Shareholders' equity, Q2 FY2024, at 2024-06-30$1.99bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure3,418Shareholders' equity, Q3 FY2024, at 2024-09-30$3.42bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure3,306Shareholders' equity, FY2024, at 2024-12-31$3.31bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure3,200Shareholders' equity, Q1 FY2025, at 2025-03-31$3.20bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure3,071Shareholders' equity, Q2 FY2025, at 2025-06-30$3.07bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure2,893Shareholders' equity, Q3 FY2025, at 2025-09-30$2.89bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure2,686Shareholders' equity, FY2025, at 2025-12-31$2.69bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure2,996Shareholders' equity, Q1 FY2026, at 2026-03-31$3.00bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure2,758Shareholders' equity, Q2 FY2026, at 2026-06-30$2.76bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure

Cash flow

Operating cash flow−$232.5m, Q2 FY2026
Capital expenditure$4.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(57.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$57.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0001649094-24-000097. Derived: 9-month figure less the 6-month figure.Report this figure(129)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$128.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(159)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$159.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure(121)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$121.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001649094-25-000098. Derived: 6-month figure less the 3-month figure.Report this figure(60.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$60.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001649094-25-000114. Derived: 9-month figure less the 6-month figure.Report this figure(111)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$111.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(166)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$166.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure(121)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$121.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001649094-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure(143)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$143.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001649094-25-000114. Derived: 9-month figure less the 6-month figure.Report this figure(225)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$224.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(281)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$280.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure(232)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$232.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001649094-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m7.3Capital expenditure, Q3 FY2023, three months to 2023-09-30$7.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0001649094-24-000097. Derived: 9-month figure less the 6-month figure.Report this figure5.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$5.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure5.7Capital expenditure, Q1 FY2024, three months to 2024-03-31$5.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure7.8Capital expenditure, Q2 FY2024, three months to 2024-06-30$7.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001649094-25-000098. Derived: 6-month figure less the 3-month figure.Report this figure4.9Capital expenditure, Q3 FY2024, three months to 2024-09-30$4.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001649094-25-000114. Derived: 9-month figure less the 6-month figure.Report this figure4.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure5.4Capital expenditure, Q1 FY2025, three months to 2025-03-31$5.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure1.8Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001649094-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure3.8Capital expenditure, Q3 FY2025, three months to 2025-09-30$3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001649094-25-000114. Derived: 9-month figure less the 6-month figure.Report this figure2.7Capital expenditure, Q4 FY2025, three months to 2025-12-31$2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001649094-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure2.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure4.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001649094-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)144.49m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares62.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3061,989,347 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0000950170-23-059395.Report this figure86.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3186,206,817 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001628280-24-021677.Report this figure98.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3098,057,870 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001649094-24-000052.Report this figure102Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30101,668,655 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0001649094-24-000097.Report this figure112Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31111,690,951 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0001649094-25-000074.Report this figure117Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30117,256,561 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001649094-25-000098.Report this figure124Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30123,693,461 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure136Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31135,690,949 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure136Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30136,033,746 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure136Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30136,196,512 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001649094-25-000114.Report this figure140Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31139,506,680 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001649094-26-000017.Report this figure144Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30144,494,106 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure

Shares outstanding: 148.81mShares outstanding, period not labelled, at 2026-08-03148,805,278 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001649094-26-000043.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.